W

ASHINGTON — It may be one of the shortest tenures in FDA history. Dr. Robert Califf, who took office as FDA commissioner last February, is preparing to vacate the premises. Like other presidential appointees, Califf must resign effective Jan. 20th, Inauguration Day.

In the absence of a new FDA chief, Dr. Stephen Ostroff, the FDA’s deputy commissioner for foods and veterinary medicine, will again become acting commissioner. It’s a role he’s familiar with; he  also served as acting commissioner from April 2015 to last February, when Califf was sworn in.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

X